Hepamate
Web18 feb 2009 · HepaLife Technologies, Inc. (OTCBB: HPLF) (FWB: HL1) (WKN: 500625), developing its cell-based bioartificial liver system, HepaMate™, as a potentially lifesaving treatment for liver failure patients, announced today that it plans for a new pivotal Phase III clinical trial in the United States. The HepaMate™ technology has previously been … Web2 giu 2009 · BOSTON--(BUSINESS WIRE)--HepaLife Technologies, Inc. (OTCBB: HPLF) (FWB: HL1) (WKN: 500625), developing its cell-based bioartificial liver system, HepaMate, as a potentially lifesaving treatment for liver failure patients, announced the appointment of four additional distinguished liver experts to its Advisory Board to further advance the …
Hepamate
Did you know?
WebOn Wednesday, January 21, 2009, a U.S. federal trademark registration was filed for HEPAMATE. The USPTO has given the HEPAMATE trademark serial number of 77653452. The current federal status of this trademark filing is ABANDONED - … WebFigure 5.6: Optimized zonation profiles for the HepaMate .....109 Figure 5.7: The oxygen profile in the standard model of the BLSS, with a full haematocrit and a blood flow rate of …
WebThe HepaMate technology has previously been tested in clinical Phase I and pivotal Phase II/III studies involving more than 200 patients. According to the company, a retrospective statistical. Pharmaceutical Business review is using cookies. Continue Learn More. Web1 nov 2010 · HepaMate™ is comprised of a blood plasma separation cartridge, a hollow-fiber bioreactor filled with proprietary porcine liver cells, a charcoal column, an …
WebAlliqua BioMedical, Inc. (ALQA) - Product Pipeline Analysis, 2016 Update Published by GlobalData at researchbeam.com [Report Price $750] 36 Pages Web21 gen 2009 · On Wednesday, January 21, 2009, a trademark application was filed for HEPAMATE with the United States Patent and Trademark Office. The USPTO has given the HEPAMATE trademark a serial number of 77653452. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, August 27, 2012.
Web1 ago 2011 · An upgraded version of HepatAssist known as Hepamate contains 14x10 9 porcine hepatocytes. The membrane pores are 0.15µm in size which prevents a physical contact between human cells and porcine hepatocytes (10, 23). Most of the BALs listed above are undergoing clinical trials in the USA, Europe and Asia.
WebWolfram Alpha brings expert-level knowledge and capabilities to the broadest possible range of people—spanning all professions and education levels. echolink conference listWeb2 giu 2009 · BOSTON--(BUSINESS WIRE)--HepaLife Technologies, Inc. (OTCBB: HPLF) (FWB: HL1) (WKN: 500625), developing its cell-based bioartificial liver system, … echolink conference server status pageWebShop No. 3, A-Wing, Garib Nawaz Bldg., Opp. Buddh Colony, Pipe Road, Kurla (W), Mumbai - 400 070.: [email protected]: +91-98217 97976 echolink compression settingWeb17 feb 2009 · HepaLife Technologies, Inc. (OTCBB: HPLF) (FWB: HL1) (WKN: 500625), developing its cell-based bioartificial liver system, HepaMate™, as a potentially … echolink conferenceWebHepaLife Technologies, a biotechnology company, has announced that it plans for a new pivotal Phase III clinical trial of its cell-based bioartificial liver system, HepaMate, as a … echolink conference serverWeb2 giu 2009 · HepaLife Technologies Inc. added a quartet of prominent liver docs to its advisory board, ahead of planned pivotal Phase III clinical trials for its HepaMate cell-based bioartificial liver system ... compression springs austin txWeb17 feb 2009 · Based in Boston, Massachusetts, HepaLife™ Technologies Inc., is developing its cell-based bioartificial liver system, HepaMate™, as a potentially lifesaving … compression spring low resistance